Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early beta-blockade in severe traumatic brain injury
ISRCTN11038397Phase 2Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of esmolol in traumatic brain injury (TBI), sponsored by North Bristol NHS Trust. Primary endpoint: Maximum tolerated dose of esmolol. Started Nov 2020; status: completed.
02
Drugs
esmolol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ISRCTN11038397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11038397.